Published in Lancet on April 05, 1975
Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q. Clin Exp Immunol (1976) 4.97
Immune complexes in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1977) 2.04
Detection of circulating antigen-antibody complexes by their inhibitory effect on the agglutination of IgG-coated particles by rheumatioid factor of Clq. Clin Exp Immunol (1976) 2.00
Immune complexes in acute and chronic liver disease. Clin Exp Immunol (1978) 1.93
Detection of immune complexes by a new assay, the polyethylene glycol precipitation-complement consumption test (PEG-CC). Clin Exp Immunol (1979) 1.74
A test for antigen--antibody complexes in human sera using IgM of rabbit antisera to human immunoglobulins. Clin Exp Immunol (1977) 1.69
Application of the solid phase C1q and Raji cell radioimmune assays for the detection of circulating immune complexes in glomerulonephritis. J Clin Invest (1978) 1.50
Circulating immune complexes in retinal vasculitis. Clin Exp Immunol (1977) 1.30
Detection of circulating IgG aggregates and immune complexes using 125I protein A from Staphylococcus aureus. Ann Rheum Dis (1976) 1.25
A nephelometric study of the reaction of monoclonal rheumatoid factor with heat aggregated gamma globulin and sera from patients with immune complex diseases. Clin Exp Immunol (1979) 1.07
Circulating immune complexes in syphilitic nephropathy. A case report. Br J Vener Dis (1978) 1.03
The effect of heat inactivation of serum on aggregation of immunoglobulins. Immunology (1979) 1.02
Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1. Immunology (1978) 0.98
Detection of circulating anticomplementary factors in chronic lung diseases. Clin Exp Immunol (1978) 0.92
Reactivity patterns of anti-phospholipid antibodies in systemic lupus erythematosus sera in relation to erythrocyte binding and complement activation. Clin Exp Immunol (1991) 0.92
Low activity of the classical complement pathway predicts short survival of patients with chronic lymphocytic leukaemia. Clin Exp Immunol (1995) 0.86
Neutropenia in rheumatoid arthritis: studies on possible contributing factors. Ann Rheum Dis (1982) 0.86
Depressed classical complement pathway activities in chronic lymphocytic leukaemia. Clin Exp Immunol (1985) 0.85
Serial measurement of circulating immune complexes in myocardial infarction. Br Heart J (1981) 0.81
Circulating immune complexes and complement concentrations in patients with alcoholic liver disease. J Clin Pathol (1982) 0.79
Abnormal responses to rubella infection. J Clin Pathol (1976) 0.78
Inhibition of antibody-dependent cellular cytotoxicity by artificial immune complexes and pathological sera. Immunology (1979) 0.77
Uptake and presentation of myelin basic protein by normal human B cells. PLoS One (2014) 0.77
Studies on the nature of heat-labile anti-complementary activity in normal human serum. Clin Exp Immunol (1979) 0.76
An experimental immunocytoma model in /LOU/M/Ws1 X CFY/F1 rats: neoplastic cells as targets of the host's immune apparatus. Immunology (1984) 0.75
A new specific assay for the detection of DNA immune complexes: its relevance in SLE. Ann Rheum Dis (1983) 0.75
Circulating and deposited immune complexes in renal disease and their clinical correlation. J Clin Pathol (1979) 0.75
Evolution of liver transplantation. Hepatology (1982) 19.54
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Chronic enterovirus infection in patients with postviral fatigue syndrome. Lancet (1988) 4.69
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
EFFECT OF PETROLEUM OILS ON THE RESPIRATION OF BEAN LEAVES. Plant Physiol (1931) 3.33
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92
Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum (1969) 2.80
Circulating immune complexes in dermatitis herpetiformis. Lancet (1973) 2.78
Growth-stimulating factor in regenerating canine liver. Lancet (1979) 2.61
Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery (1968) 2.58
Cerebral perfusion pressure: management protocol and clinical results. J Neurosurg (1995) 2.58
Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc (1981) 2.49
Acute neurological complications after liver transplantation with particular reference to intraoperative cerebral air embolus. Ann Surg (1978) 2.48
Portal diversion for the treatment of glycogen storage disease in humans. Ann Surg (1973) 2.44
Hepatotrophic effects of FK506 in dogs. Transplantation (1991) 2.39
The Eck fistula in animals and humans. Curr Probl Surg (1983) 2.35
Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A (1994) 2.35
Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg (1983) 2.33
Antigen-specific human T lymphocyte clones: induction, antigen specificity, and MHC restriction of influenza virus-immune clones. J Immunol (1982) 2.30
The hepatotropic influence of cyclosporine. Surgery (1990) 2.27
SEROTYPING FOR HOMOTRANSPLANTATION. VII. SELECTION OF KIDNEY DONORS FOR THIRTY-TWO RECIPIENTS. Ann N Y Acad Sci (1966) 2.25
Defective yeast opsonization and C2 deficiency in atopic patients. Clin Exp Immunol (1978) 2.14
Managanese oxidation by Sphaerotilus discophorus. J Bacteriol (1966) 2.12
Human cadaveric renal transplantation. Report of twenty cases. Br Med J (1965) 2.12
B-lymphocyte alloantigens associated with systemic lupus erythematosus. N Engl J Med (1978) 2.11
Human renal transplants. I. Glomerular changes. Lab Invest (1967) 2.06
Augmentation of rat liver regeneration by FK 506 compared with cyclosporin. Lancet (1989) 2.01
Genetic differences between primary and secondary sicca syndrome. N Engl J Med (1979) 1.93
Infections in recipients of liver homografts. N Engl J Med (1968) 1.92
The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons. Surg Gynecol Obstet (1975) 1.91
Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet (1985) 1.89
Functional imprinting and epigenetic modification of the human SNRPN gene. Hum Mol Genet (1993) 1.84
Progress in homotransplantation of the liver. Adv Surg (1966) 1.83
Fungus infections after liver transplantation. Ann Surg (1977) 1.81
Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. Arch Surg (1979) 1.80
Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg (1968) 1.78
Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation (1966) 1.78
The quality of life after liver transplantation. Transplant Proc (1979) 1.78
Liver regeneration in dogs: morphologic and chemical changes. J Surg Res (1978) 1.78
Prognostic factors in sterile pancreatic necrosis. Gastroenterology (1992) 1.77
Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration. Surg Gynecol Obstet (1975) 1.74
Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver. Surg Gynecol Obstet (1980) 1.72
Homotransplantation of the liver. Transplantation (1967) 1.71
Augmenter of liver regeneration: its place in the universe of hepatic growth factors. Hepatology (1994) 1.70
Human renal transplants. II. Immunofluorescent and immunoferritin studies. Lab Invest (1968) 1.69
Auxiliary liver transplantation: effect of host portacaval shunt. Experimental and clinical observations. Arch Surg (1966) 1.66
Portacaval shunt in hyperlipoproteinaemia. Lancet (1973) 1.66
The effect of splanchnic viscera removal upon canine liver regeneration. Surg Gynecol Obstet (1978) 1.63
Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses. J Exp Med (1980) 1.61
Derivation and biochemical characterization of an enterovirus group-specific monoclonal antibody. Intervirology (1987) 1.57
Postviral syndrome--how can a diagnosis be made? A study of patients undergoing a Monospot test. J R Soc Med (1989) 1.55
Intraportal insulin protects from the liver injury of portacaval shunt in dogs. Lancet (1975) 1.55
The effect of partial portacaval transposition on the canine liver. Surgery (1967) 1.54
Renal homotransplantation with venous outflow or infusion of antigen into the portal vein of dogs or pigs. Transplantation at portal site. Transplantation (1977) 1.54
Effects of long-chain triglyceride emulsions on reticuloendothelial system function in humans. JPEN J Parenter Enteral Nutr (1990) 1.53
Liver replacement for alpha1-antitrypsin deficiency. Surgery (1977) 1.53
Further studies on the preparation of the immunosuppressive alpha-2 protein fraction from the serum and its assay in mice. Immunology (1966) 1.53
Liver replacement for pediatric patients. Pediatrics (1979) 1.51
Clinical and pathologic observations after orthotopic transplantation of the human liver. Surg Gynecol Obstet (1969) 1.51
Infections complicating orthotopic liver transplantation: a study emphasizing graft-related septicemia. Arch Surg (1976) 1.50
Acid deposition and forest decline. Environ Sci Technol (1983) 1.48
Circulating immune complexes in tuberculosis. Thorax (1981) 1.47
Peripheral blood leucocyte changes during human renal allograft rejection. Transplantation (1971) 1.45
Inhibition of antibody production by ribonucleases. Immunology (1966) 1.44
Decline in survival after liver transplantation. Arch Surg (1980) 1.39
Autopsy findings in a long-surviving liver recipient. N Engl J Med (1973) 1.36
Pathology of liver transplantation. Transplant Rev (1969) 1.36
The specific influence of nonhepatic splanchnic venous blood flow on the liver. Surg Forum (1965) 1.34
The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs. Surg Gynecol Obstet (1975) 1.33
Virus-induced obstruction of the ureteric and cystic duct in allograft recipients. Transplant Proc (1973) 1.33
Human renal transplants. 3. Immunopathologic studies. Lab Invest (1970) 1.31
Human papovavirus in Papanicolaou smears of urinary sediment detected by transmission electron microscopy. J Clin Pathol (1977) 1.31
Current policies in hepatic transplantation: candidacy of patients with alcoholic liver disease or preformed antidonor antibodies and a reappraisal of biliary duct reconstruction. Ann N Y Acad Sci (1975) 1.30
The epidemiology of Plasmodium falciparum malaria in two Cameroonian villages: Simbok and Etoa. Am J Trop Med Hyg (2001) 1.28
Demonstration of two disease specific antigens in circulating immune complexes. Clin Exp Immunol (1979) 1.26
Liver transplantation of Budd-Chiari syndrome. JAMA (1976) 1.26
Renal transplantation in children. Analysis of 25 consecutive transplants in 19 recipients. Arch Dis Child (1972) 1.20
Alternate-pathway complement fixation by IgA in the skin in dermatitis herpetiformis. Lancet (1973) 1.20